Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of DexCom (NASDAQ:DXCM) through any online brokerage.
Other companies in DexCom’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
DexCom has a consensus price target of $91.20.
The stock price for DexCom (NASDAQ: DXCM) is $85.84 last updated October 12, 2026 at 3:33 PM EDT.
There are no upcoming dividends for DexCom.
DexCom does not have any upcoming earnings scheduled.
There is no upcoming split for DexCom.
DexCom is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.